Recent reports have shown that aberrant LSD2 expression is often associated with dysregulation of histone activity, which contributes to aberrant gene expression in some cancers such as glioblastoma, breast cancer, pancreatic cancer, and GC [102]. Here, KDM1B is linked to breast cancer.